Report Detail

Medical Devices & Consumables Global Newborn Blood Screening Systems Market 2026 by Company, Regions, Type and Application, Forecast to 2032

  • RnM4704254
  • |
  • 01 June, 2026
  • |
  • Global
  • |
  • 90 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Newborn Blood Screening Systems market size was valued at US$ 727 million in 2025 and is forecast to a readjusted size of US$ 1186 million by 2032 with a CAGR of 7.3% during review period.
Newborn blood screening systems, also known as newborn screening (NBS), are public health programs designed to identify certain disorders in newborn babies shortly after birth. These systems involve taking a few drops of blood from a baby"s heel, usually within the first 24 to 48 hours after birth, and testing it for a variety of genetic, metabolic, and developmental conditions.
The tests conducted through newborn blood screening systems can vary based on location, but they often include screenings for disorders such as phenylketonuria (PKU), congenital hypothyroidism, cystic fibrosis, sickle cell disease, and many others. Early detection of these conditions allows for early intervention and treatment, which can significantly improve the baby"s health outcomes and quality of life.
Newborn blood screening is typically mandatory or strongly recommended in many countries as part of standard newborn care. It"s an essential preventive measure aimed at early identification of potential health issues, enabling timely medical interventions that can prevent or minimize the impact of certain conditions on a child"s development.
Newborn blood screening systems include screening kits, consumables, instruments and software.
Market Drivers: Rising Prevalence of Disorders: The increasing incidence of genetic, metabolic, and congenital disorders among newborns drives the demand for comprehensive screening systems.
Government Initiatives: Government-led programs mandating newborn screening in many countries promote the adoption of screening systems, ensuring early detection and intervention for better health outcomes.
Rising Healthcare Expenditure: Increased healthcare spending, especially in developing regions, allows for better infrastructure and accessibility to screening systems and services.
Market Restrictions: Cost Constraints: High initial setup costs for screening equipment and ongoing operational expenses can limit the implementation of comprehensive newborn screening programs in certain regions or healthcare settings.
Limited Access to Advanced Technology: Some regions, especially in low-resource settings, may lack access to sophisticated screening technologies, hindering comprehensive screening programs.
Variability in Healthcare Policies: Differences in healthcare policies and regulations across regions can affect the standardization and uniformity of newborn screening programs.
This report is a detailed and comprehensive analysis for global Newborn Blood Screening Systems market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Newborn Blood Screening Systems market size and forecasts, in consumption value ($ Million), 2021-2032
Global Newborn Blood Screening Systems market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Newborn Blood Screening Systems market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Newborn Blood Screening Systems market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Newborn Blood Screening Systems
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Newborn Blood Screening Systems market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include PerkinElmer, Waters Corporation, Danaher, Thermo Fisher, Trivitron Healthcare, Agilent Technologies, Bio-Rad Laboratories, Zivak Technologies, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Newborn Blood Screening Systems market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Instrument and Kits
Consumables
Software
Market segment by Application
Hospital
Independent Laboratories
Other
Market segment by players, this report covers
PerkinElmer
Waters Corporation
Danaher
Thermo Fisher
Trivitron Healthcare
Agilent Technologies
Bio-Rad Laboratories
Zivak Technologies
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Newborn Blood Screening Systems product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Newborn Blood Screening Systems, with revenue, gross margin, and global market share of Newborn Blood Screening Systems from 2021 to 2026.
Chapter 3, the Newborn Blood Screening Systems competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Newborn Blood Screening Systems market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newborn Blood Screening Systems.
Chapter 13, to describe Newborn Blood Screening Systems research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Newborn Blood Screening Systems by Type
    • 1.3.1 Overview: Global Newborn Blood Screening Systems Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Newborn Blood Screening Systems Consumption Value Market Share by Type in 2025
    • 1.3.3 Instrument and Kits
    • 1.3.4 Consumables
    • 1.3.5 Software
  • 1.4 Global Newborn Blood Screening Systems Market by Application
    • 1.4.1 Overview: Global Newborn Blood Screening Systems Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Independent Laboratories
    • 1.4.4 Other
  • 1.5 Global Newborn Blood Screening Systems Market Size & Forecast
  • 1.6 Global Newborn Blood Screening Systems Market Size and Forecast by Region
    • 1.6.1 Global Newborn Blood Screening Systems Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Newborn Blood Screening Systems Market Size by Region, (2021-2032)
    • 1.6.3 North America Newborn Blood Screening Systems Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Newborn Blood Screening Systems Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Newborn Blood Screening Systems Market Size and Prospect (2021-2032)
    • 1.6.6 South America Newborn Blood Screening Systems Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Newborn Blood Screening Systems Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 PerkinElmer
    • 2.1.1 PerkinElmer Details
    • 2.1.2 PerkinElmer Major Business
    • 2.1.3 PerkinElmer Newborn Blood Screening Systems Product and Solutions
    • 2.1.4 PerkinElmer Newborn Blood Screening Systems Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 PerkinElmer Recent Developments and Future Plans
  • 2.2 Waters Corporation
    • 2.2.1 Waters Corporation Details
    • 2.2.2 Waters Corporation Major Business
    • 2.2.3 Waters Corporation Newborn Blood Screening Systems Product and Solutions
    • 2.2.4 Waters Corporation Newborn Blood Screening Systems Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Waters Corporation Recent Developments and Future Plans
  • 2.3 Danaher
    • 2.3.1 Danaher Details
    • 2.3.2 Danaher Major Business
    • 2.3.3 Danaher Newborn Blood Screening Systems Product and Solutions
    • 2.3.4 Danaher Newborn Blood Screening Systems Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Danaher Recent Developments and Future Plans
  • 2.4 Thermo Fisher
    • 2.4.1 Thermo Fisher Details
    • 2.4.2 Thermo Fisher Major Business
    • 2.4.3 Thermo Fisher Newborn Blood Screening Systems Product and Solutions
    • 2.4.4 Thermo Fisher Newborn Blood Screening Systems Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Thermo Fisher Recent Developments and Future Plans
  • 2.5 Trivitron Healthcare
    • 2.5.1 Trivitron Healthcare Details
    • 2.5.2 Trivitron Healthcare Major Business
    • 2.5.3 Trivitron Healthcare Newborn Blood Screening Systems Product and Solutions
    • 2.5.4 Trivitron Healthcare Newborn Blood Screening Systems Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Trivitron Healthcare Recent Developments and Future Plans
  • 2.6 Agilent Technologies
    • 2.6.1 Agilent Technologies Details
    • 2.6.2 Agilent Technologies Major Business
    • 2.6.3 Agilent Technologies Newborn Blood Screening Systems Product and Solutions
    • 2.6.4 Agilent Technologies Newborn Blood Screening Systems Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Agilent Technologies Recent Developments and Future Plans
  • 2.7 Bio-Rad Laboratories
    • 2.7.1 Bio-Rad Laboratories Details
    • 2.7.2 Bio-Rad Laboratories Major Business
    • 2.7.3 Bio-Rad Laboratories Newborn Blood Screening Systems Product and Solutions
    • 2.7.4 Bio-Rad Laboratories Newborn Blood Screening Systems Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.8 Zivak Technologies
    • 2.8.1 Zivak Technologies Details
    • 2.8.2 Zivak Technologies Major Business
    • 2.8.3 Zivak Technologies Newborn Blood Screening Systems Product and Solutions
    • 2.8.4 Zivak Technologies Newborn Blood Screening Systems Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Zivak Technologies Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Newborn Blood Screening Systems Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Newborn Blood Screening Systems by Company Revenue
    • 3.2.2 Top 3 Newborn Blood Screening Systems Players Market Share in 2025
    • 3.2.3 Top 6 Newborn Blood Screening Systems Players Market Share in 2025
  • 3.3 Newborn Blood Screening Systems Market: Overall Company Footprint Analysis
    • 3.3.1 Newborn Blood Screening Systems Market: Region Footprint
    • 3.3.2 Newborn Blood Screening Systems Market: Company Product Type Footprint
    • 3.3.3 Newborn Blood Screening Systems Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Newborn Blood Screening Systems Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Newborn Blood Screening Systems Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Newborn Blood Screening Systems Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Newborn Blood Screening Systems Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Newborn Blood Screening Systems Consumption Value by Type (2021-2032)
  • 6.2 North America Newborn Blood Screening Systems Market Size by Application (2021-2032)
  • 6.3 North America Newborn Blood Screening Systems Market Size by Country
    • 6.3.1 North America Newborn Blood Screening Systems Consumption Value by Country (2021-2032)
    • 6.3.2 United States Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Newborn Blood Screening Systems Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Newborn Blood Screening Systems Consumption Value by Type (2021-2032)
  • 7.2 Europe Newborn Blood Screening Systems Consumption Value by Application (2021-2032)
  • 7.3 Europe Newborn Blood Screening Systems Market Size by Country
    • 7.3.1 Europe Newborn Blood Screening Systems Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 7.3.3 France Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Newborn Blood Screening Systems Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Newborn Blood Screening Systems Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Newborn Blood Screening Systems Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Newborn Blood Screening Systems Market Size by Region
    • 8.3.1 Asia-Pacific Newborn Blood Screening Systems Consumption Value by Region (2021-2032)
    • 8.3.2 China Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 8.3.5 India Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Newborn Blood Screening Systems Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Newborn Blood Screening Systems Consumption Value by Type (2021-2032)
  • 9.2 South America Newborn Blood Screening Systems Consumption Value by Application (2021-2032)
  • 9.3 South America Newborn Blood Screening Systems Market Size by Country
    • 9.3.1 South America Newborn Blood Screening Systems Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Newborn Blood Screening Systems Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Newborn Blood Screening Systems Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Newborn Blood Screening Systems Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Newborn Blood Screening Systems Market Size by Country
    • 10.3.1 Middle East & Africa Newborn Blood Screening Systems Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Newborn Blood Screening Systems Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Newborn Blood Screening Systems Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Newborn Blood Screening Systems Market Drivers
  • 11.2 Newborn Blood Screening Systems Market Restraints
  • 11.3 Newborn Blood Screening Systems Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Newborn Blood Screening Systems Industry Chain
  • 12.2 Newborn Blood Screening Systems Upstream Analysis
  • 12.3 Newborn Blood Screening Systems Midstream Analysis
  • 12.4 Newborn Blood Screening Systems Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Newborn Blood Screening Systems. Industry analysis & Market Report on Newborn Blood Screening Systems is a syndicated market report, published as Global Newborn Blood Screening Systems Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Newborn Blood Screening Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report